User profiles for T. Vandenberg

Timo van den Berg

Byondis BV
Verified email at byondis.com
Cited by 18579

[PDF][PDF] Use of adjuvant bisphosphonates and other bone-modifying agents in breast cancer: a Cancer Care Ontario and American Society of Clinical Oncology clinical …

…, R Gupta, M Mates, B Moy, T Vandenberg… - J Clin …, 2017 - medicalrp.com.mx
Purpose: To make recommendations regarding the use of bisphosphonates and other bone-modifying
agents as adjuvant therapy for patients with breast cancer. Methods: Cancer Care …

Signal regulatory proteins in the immune system

…, F Cochrane, AN Barclay, TK van den Berg - The Journal of …, 2005 - journals.aai.org
… In addition to the regulatory functions in macrophages, interactions between CD47 on T
cells and SIRP on DCs have been shown to regulate, in a bidirectional fashion, DC and T cell …

[HTML][HTML] Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for …

…, N Bouganim, C Doyle, JP Hiller, T Vandenberg… - Annals of …, 2021 - Elsevier
Background In the phase III IMpassion130 trial, combining atezolizumab with first-line
nanoparticle albumin-bound-paclitaxel for advanced triple-negative breast cancer (aTNBC) …

[PDF][PDF] Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline …

…, L Deschenes, J Douma, TA Vandenberg… - Journal of Clinical …, 1999 - Citeseer
Purpose: This phase III study compared docetaxel with mitomycin plus vinblastine (MV) in
patients with metastatic breast cancer (MBC) progressing despite previous anthracycline-…

Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in …

…, J Myles, A Arnold, T Vandenberg… - Journal of Clinical …, 1998 - ascopubs.org
PURPOSE To determine the relative efficacy of an intensive cyclophosphamide, epirubicin,
and fluorouracil (CEF) adjuvant chemotherapy regimen compared with cyclophosphamide, …

The effects of work-related and individual factors on the Work Ability Index: a systematic review

T Van den Berg, L Elders, B de Zwart… - Occupational and …, 2008 - oem.bmj.com
Objectives. This paper systematically reviews the scientific literature on the effects of
individual and work related factors on the work ability index. Methods. Studies on work ability …

[HTML][HTML] Combination anastrozole and fulvestrant in metastatic breast cancer

…, WE Barlow, KS Albain, TA Vandenberg… - … England Journal of …, 2012 - Mass Medical Soc
Background The aromatase inhibitor anastrozole inhibits estrogen synthesis. Fulvestrant
binds and accelerates degradation of estrogen receptors. We hypothesized that these two …

External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node …

…, E Yu, T Vandenberg, J Younus, K Potvin, T Sexton… - The Lancet, 2019 - thelancet.com
Background Whole breast irradiation delivered once per day over 3–5 weeks after breast
conserving surgery reduces local recurrence with good cosmetic results. Accelerated partial …

The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria

…, CD Dijkstra, TK van den Berg - Blood, The Journal …, 2009 - ashpublications.org
van den Bergvan den Berg … Statistics: 2-tailed Student t test. (B) Flow cytometric
analysis of CD163 expression on monocytes using EDhu1, EDhu2, EDhu3 and EDhu4 mAb. …

[PDF][PDF] Randomized phase II study comparing two schedules of everolimus in patients with recurrent/metastatic breast cancer: NCIC Clinical Trials Group IND. 163.

…, S Chia, K Pritchard, A Eisen, T Vandenberg… - Clin Oncol, 2009 - researchgate.net
… A B S T R A C T … Gelmon, Brian Norris, Hagen Kennecke, Stephen Chia, Kathleen
Pritchard, Andrea Eisen, Ted Vandenberg, Marianne Taylor Collection and assembly of data …